Acrodermatitis perstans. Generalization following therapy with nystatin.
D000169:Acrodermatitis / Q000139:chemically induced* / Q000209:etiology / Q000473:pathology; D000328:Adult; D002179:Candidiasis, Cutaneous / Q000150:complications; D002908:Chronic Disease; D006801:Humans; D006967:Hypersensitivity / Q000150:complications; D008297:Male; D008875:Middle Aged; D009761:Nystatin / Q000009:adverse effects*
D009761:Nystatin